Liquidia (NASDAQ:LQDA) Director Stephen Bloch Sells 2,064 Shares of Stock

Liquidia Corporation (NASDAQ:LQDA) Director Stephen Bloch sold 2,064 shares of the business’s stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $64.14, for a total value of $132,384.96. Following the completion of the sale, the director directly owned 1,785,242 shares of the company’s stock, valued at approximately $114,505,421.88. The trade was a 0.12% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Liquidia Price Performance

Shares of LQDA opened at $63.90 on Tuesday. The company has a debt-to-equity ratio of 1.18, a quick ratio of 2.03 and a current ratio of 2.22. The firm has a market cap of $5.68 billion, a PE ratio of 456.46 and a beta of 0.57. The firm’s 50 day moving average price is $47.32 and its 200 day moving average price is $39.87. Liquidia Corporation has a twelve month low of $11.85 and a twelve month high of $66.78.

Liquidia (NASDAQ:LQDA) last posted its earnings results on Monday, May 11th. The company reported $0.52 EPS for the quarter, topping the consensus estimate of $0.41 by $0.11. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. The company had revenue of $132.87 million during the quarter, compared to the consensus estimate of $119.44 million. The firm’s quarterly revenue was up 4187.1% compared to the same quarter last year. As a group, research analysts expect that Liquidia Corporation will post 2.97 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the company. HC Wainwright raised their target price on Liquidia from $67.00 to $75.00 and gave the company a “buy” rating in a report on Friday. Wells Fargo & Company upped their price target on Liquidia from $51.00 to $62.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 12th. Raymond James Financial reissued a “strong-buy” rating and set a $68.00 price objective on shares of Liquidia in a report on Thursday. Wall Street Zen raised Liquidia from a “buy” rating to a “strong-buy” rating in a research note on Saturday, May 16th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Liquidia in a report on Tuesday, April 21st. Three analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Liquidia currently has a consensus rating of “Moderate Buy” and a consensus price target of $55.63.

Liquidia News Summary

Here are the key news stories impacting Liquidia this week:

• Positive Sentiment: Liquidia announced it will be added to the S&P SmallCap 600 Index on June 22, a move that can create incremental buying from index-tracking funds and improve trading liquidity. Liquidia Corporation Announces Inclusion in the S&P SmallCap 600 Index
• Positive Sentiment: Recent market commentary highlighted continued strength in LQDA shares and suggested the stock remains undervalued relative to its growth outlook, reinforcing bullish sentiment. Liquidia Corp (LQDA) Stock Up 3.4% and Still Undervalued — GF Score: 75/100
• Neutral Sentiment: HC Wainwright raised its price target to $75 and several analysts continue to rate the stock a Buy or Strong Buy, keeping sentiment constructive. MarketBeat LQDA coverage
• Negative Sentiment: Director Stephen Bloch sold 82,736 shares, and fellow director Paul B. Manning sold 200,000 shares, which may weigh on sentiment because insider selling can signal reduced confidence or profit-taking. Liquidia (NASDAQ:LQDA) Director Sells $5,375,357.92 in Stock

Institutional Investors Weigh In On Liquidia

Hedge funds have recently bought and sold shares of the company. Farallon Capital Management LLC increased its stake in shares of Liquidia by 102.1% in the third quarter. Farallon Capital Management LLC now owns 8,565,638 shares of the company’s stock worth $194,783,000 after purchasing an additional 4,326,876 shares during the period. TCG Crossover Management LLC acquired a new position in shares of Liquidia during the 3rd quarter worth about $38,887,000. Caprock Group LLC bought a new stake in Liquidia during the 3rd quarter valued at approximately $37,114,000. MPM Bioimpact LLC boosted its stake in Liquidia by 600.4% during the 4th quarter. MPM Bioimpact LLC now owns 1,400,869 shares of the company’s stock valued at $48,316,000 after purchasing an additional 1,200,869 shares during the period. Finally, Voloridge Investment Management LLC acquired a new stake in Liquidia in the 3rd quarter valued at approximately $12,571,000. 64.54% of the stock is currently owned by institutional investors.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).